AFP and neoplasm: Factors that were associated with probability of LT included HgbA1c (continuous variable: HR, 0.82; 95% CI, 0.68-0.99; P = 0.04), blood type (AB+B versus A+O: HR, 1.73; 95% CI, 1.30-2.30; P < 0.001), tumor burden (1 tumor 3–5 cm: HR, 0.64; 95% CI, 0.51-0.81; P < 0.001; 3 tumors: HR, 0.48; 95% CI, 0.30-0.76; P = 0.002), MELD-Na at listing ≥15 (HR, 2.99; 95% CI, 1.73-5.17; P < 0.001), AFP at listing ≥20 ng/mL (HR, 1.38; 95% CI, 1.13-1.68; P = 0.001), and number of LRT (LRT 2-3: HR, 0.77; 95% CI, 0.62-0.95; P = 0.01; LRT >3: HR, 0.47; 95% CI, 0.36-0.62; P < 0.001).